Tips and Insights
Here are some tips & insights extracted from C.E.L.forpharma’s courses. Some are plain definitions of terms that often cause confusion, others offer invaluable advice for better planning and decision-making. Use the filters to find insights related to your functional area.
Expert insight
10 Critical success factors for pharma lifecycle management
| Expert: | Dr. Neal Hansen |
| Course: | Late Stage Pharma Lifecycle Management |
Expert insight
11 simple rules of business model transformation in pharma and medtech
| Expert: | Prof. Dr. Brian D. Smith |
| Course: | Transforming Your Pharma & Medtech Business Model |
Expert insight
13 Checkpoints to critically assess the quality of your brand marketing plans
| Expert: | Edouard Demeire |
| Course: | The Pharma Brand Planning Course |
Expert insight
3 main problem areas in pharma business development
| Expert: | Martin Austin |
| Course: | The Pharma Business Development Course |
Expert insight
An often overlooked element in the process of designing Patient Support Programmes
| Expert: | Prof. John Weinman & Jonny Duder |
| Course: | Principles of Patient Adherence & Support Solutions |
Expert insight
Are you up to date on the use of internet by European physicians?
| Expert: | Ruud Kooi & Annelien Van Boxlaer |
| Course: | The Strategic Digital Pharma Marketing Course |
Expert insight
Can you forecast the relationship between your level of promotion and your sales?
| Expert: | Gary Johnson |
| Course: | The Pharma Forecasting Course |
Expert insight
Choose the right generic strategy for your mature brands!
| Expert: | Dr. Neal Hansen |
| Course: | Late Stage Pharma Lifecycle Management |
Expert insight
Do you have an effective market access planning process in place for new brands?
| Expert: | Mark Silvey & Dr. Nick Proctor |
| Course: | Principles of Pharma Market Access in Europe |
Expert insight
Do you know the 5 categories of payers and their respective roles and drivers?
| Expert: | Mark Silvey & Dr. Nick Proctor |
| Course: | Principles of Pharma Market Access in Europe |
Expert insight
Do you know the difference between Health Economic Evaluations and Health Technology Assessments?
| Expert: | Prof. Dr. Lieven Annemans |
| Course: | The Health Technology Assessment Course |
Expert insight
Do you know the key determinants of Parallel Trade?
| Expert: | Gary Johnson |
| Course: | Value Pricing for Market Access |
Expert insight
Do you know the key drivers of price sensitivity for pharmaceuticals?
| Expert: | Gary Johnson |
| Course: | Value Pricing for Market Access |
Expert insight
Do you know what a QALY is, and how to calculate it?
| Expert: | Prof. Dr. Lieven Annemans |
| Course: | Health Economics for Non-Health-Economists |
Expert insight
How are price-demand curves for pharmaceuticals determined?
| Expert: | Gary Johnson |
| Course: | Value Pricing for Market Access |
Expert insight
How pharma can provide more ‘value’ to payers and patients
| Expert: | Gary Johnson |
| Course: | Value Pricing for Market Access |
Expert insight
How to measure your company's reputation?
| Expert: | Stefan Gijssels |
| Course: | Improve Reputation for Better Results in Pharma |
Expert insight
Not only is Market Access increasingly important, it also requires a new approach
| Expert: | Mark Silvey & Dr. Nick Proctor |
| Course: | Principles of Pharma Market Access in Europe |
Expert insight
Preference scores from conjoint studies can be converted into useful market share estimates.
| Expert: | Gary Johnson |
| Course: | The Pharma Forecasting Course |
Expert insight
Test your understanding of SWOTs
| Expert: | Edouard Demeire |
| Course: | The Pharma Brand Planning Course |